Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs Rex MD

Alan Meds
Graded #99

Higher grade

vs+0.8999999999999915
Rex MD
Graded #112

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 70.2/100, but only just.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options. Rex MD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +12
72
60
Dose & formulationRex MD +2
75
77
Clinical oversightRex MD +2
82
84
Labs & monitoringEven
53
53
FulfillmentRex MD +11
78
89
Contract termsEven
55
55
Alan Meds · left barRex MD · right bar

The numbers

MetricAlan MedsRex MD
WeighScore71.1/10070.2/100
GradeCC
Scorecard rank#99#112
Semaglutide$158/mo (compounded)$199/mo (brand-name)
Tirzepatide$295/mo (compounded)$349/mo (brand Zepbound)
Coverage46 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Alan Meds

Graded #99 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
Rex MD

Graded #112 · C

Strengths

  • Flat $199/mo program bundles consult, medication and overnight shipping
  • Brand-name semaglutide and Zepbound vials, not just compounded
  • Serves all 50 states, fully online
  • LegitScript certified with US-based, state-licensed providers
  • Backed by parent company LifeMD

Where it loses points

  • Does not accept insurance
  • Marketed primarily to men via a men's-health platform
  • Zepbound vial cost rises with dose titration
  • Branded-only program costs more than compounded options

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard